5Zunino F,Dallavalleb S,Laccabuea D,et al.Current status and perspectives in the development of camptothecins[J].Curr Pharm Des,2002,8(27):2505-2520.
6Slichenmyer WJ,Rowinsky EK,Donehower RC,et al.The current status of camptothecin analogues as antitumor agents[J].J Nat Canc Inst,1993,85(4):271-291.
7Aisner J,Musanti R,Beers S,et al.Sequencing topotecan and etoposide plus cisplatin to overcome topoisomerase Ⅰ and Ⅱ resistance:a pharmacodynamically based phase Ⅰ trial[J].Clin Cancer Res,2003,9(7):2504-2509.
8Guichard S,Arnould S,Hennebelle I,et al.Combination of oxaliplatin and irinotecan on human colon cancer cell lines:activity in vitro and in vivo[J].Anticancer Drugs,2001,12(9):741-751.
9Wu HG,Choy H.Irinotecan in combination with radiation therapy for small-cell and non-small-cell lung cancer[J].Oncology(Huntingt),2002,16(9):13-18.
10Kim JS,Amorino GP,Pyo H,et al.Radiation enhancement by the combined use of topoisomerase Ⅰ inhibitors,RFS-2000 or CPT-11,and topoisomerase Ⅱ inhibitor etoposide in human lung cancer cells[J].Radiother Oncol,2002,62(1):61-67.
